Puretech Health Plc Quick Ratio (PRTC) starting from the fourth quarter 2025 to fourth quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Puretech Health Plc  (NASDAQ: PRTC)

Puretech Health Plc's Quick Ratio

PRTC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the fourth quarter 2025, Quick Ratio deteriorated to 5.59 above company average Quick Ratio.

Within Major Pharmaceutical Preparations industry 175 other companies have achieved higher Quick Ratio than Puretech Health Plc in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from 456 to 747.

Explain Quick Ratio?
How much Cash & cash equivalents PRTC´s has?
What are PRTC´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PRTC Quick Ratio (Dec 31 2025)
Q4		 0
Q3		 0
Q2		 0
Q1		 (Dec 31 2024)
Q4
Y / Y Current Liabilities Change -32.3 % 11.89 % -36.42 % 11.89 % -28.35 %
Y / Y Cash & cash equivalent Change -7.77 % -7.77 % -16.09 % -7.77 % 38.36 %
Quick Ratio MRQ 5.59 5.59 5.59 5.59 4.1
PRTC's Total Ranking # 747 # 456 # # #
Seq. Current Liabilities Change 0 % 0 % 0 % -32.3 % 65.28 %
Seq. Cash & cash equivalent Change 0 % 0 % 0 % -7.77 % 0 %



Quick Ratio fourth quarter 2025 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 176
Healthcare Sector # 284
Overall Market # 747


Quick Ratio Statistics
High Average Low
12.82 4.69 2.12
(Dec 31 2021)   (Dec 31 2023)




Financial Statements
Puretech Health Plc's Current Liabilities $ 46 Millions Visit PRTC's Balance sheet
Puretech Health Plc's Cash & cash equivalent $ 259 Millions Visit PRTC's Balance sheet
Source of PRTC's Sales Visit PRTC's Sales by Geography


Cumulative Puretech Health Plc's Quick Ratio

PRTC's Quick Ratio for the trailling 12 Months

PRTC Quick Ratio

 (Dec 31 2025)
12 Months		 0
12 Months		 0
12 Months		 0
12 Months		 (Dec 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth -17.31 % -17.42 % -22.47 % -4.45 % -10.24 %
Y / Y Cash & cash equivalent TTM Growth -10 % -1.44 % 8.46 % 7.63 % 18.51 %
Quick Ratio TTM 5.59 5.1 5.33 4.93 5.14
Total Ranking TTM # 4245 # 3472 # # #
Seq. Current Liabilities TTM Growth -10.66 % 2.43 % -11.59 % 2.2 % -10.78 %
Seq. Cash & cash equivalent TTM Growth -2.06 % -2.02 % -4.4 % -1.89 % 7.25 %

Quick ratio ranking by company, industry and sector >> Back to PRTC Financial Strength Comparisons >> Go to Compare PRTC Quick Ratio to its Competitors

On the trailing twelve months basis Current Liabilities decreased faster than Puretech Health Plc's average Cash & cash equivalent, this led to increase in in Puretech Health Plc's Quick Ratio to 5.59, above PRTC average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 472 other companies have achieved higher Quick Ratio than Puretech Health Plc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2025 from 3472 to 4245.

Explain Quick Ratio?
How much Cash & cash equivalents PRTC´s has?
What are PRTC´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 473
Healthcare Sector # 957
Within the Market # 4245


trailing twelve months Quick Ratio Statistics
High Average Low
6.78 4.22 1.89
(Dec 31 2024)   0




Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2025 MRQ Cash & cash equivalentDec 31 2025 MRQ Current Liabilities
Ocular Therapeutix Inc   15.36 $ 737.060  Millions$ 47.989  Millions
Nuvalent Inc   15.05 $ 1,371.952  Millions$ 91.171  Millions
Mereo Biopharma Group Plc  14.66 $ 41.387  Millions$ 2.824  Millions
Bioharvest Sciences Inc   14.57 $ 46.050  Millions$ 3.160  Millions
Immunome Inc   14.55 $ 654.782  Millions$ 44.990  Millions
Eupraxia Pharmaceuticals Inc   14.51 $ 80.563  Millions$ 5.551  Millions
Climb Bio Inc   14.47 $ 101.080  Millions$ 6.984  Millions
Synlogic Inc   14.41 $ 14.668  Millions$ 1.018  Millions
Cervomed Inc   14.35 $ 20.864  Millions$ 1.454  Millions
Bicara Therapeutics Inc   14.33 $ 414.801  Millions$ 28.949  Millions
Tyra Biosciences Inc   14.15 $ 256.003  Millions$ 18.094  Millions
Rezolute Inc   14.09 $ 167.858  Millions$ 11.912  Millions
Cogent Biosciences Inc   14.08 $ 900.765  Millions$ 63.953  Millions
Keros Therapeutics Inc   14.08 $ 287.415  Millions$ 20.414  Millions
Amylyx Pharmaceuticals Inc   13.97 $ 316.979  Millions$ 22.688  Millions
Oric Pharmaceuticals Inc   13.79 $ 281.488  Millions$ 20.417  Millions
Vtv Therapeutics Inc   13.39 $ 88.932  Millions$ 6.641  Millions
Agios Pharmaceuticals Inc   13.39 $ 854.425  Millions$ 63.814  Millions
Vera Therapeutics Inc   13.37 $ 714.589  Millions$ 53.455  Millions
Chemocentryx Inc.  13.22 $ 0.736  Millions$ 0.056  Millions
Dianthus Therapeutics Inc   13.16 $ 404.295  Millions$ 30.732  Millions
Novo Nordisk A  12.96 $ 761.785  Millions$ 58.768  Millions
Rallybio Corporation  12.96 $ 54.736  Millions$ 4.223  Millions
Damora Therapeutics Inc   12.84 $ 257.624  Millions$ 20.066  Millions
Aptevo Therapeutics Inc   12.77 $ 42.119  Millions$ 3.298  Millions
Immuneering Corporation  12.77 $ 128.645  Millions$ 10.074  Millions
Harmony Biosciences Holdings inc   12.69 $ 775.340  Millions$ 61.093  Millions
Chemomab Therapeutics Ltd   12.61 $ 10.366  Millions$ 0.822  Millions
Protagonist Therapeutics inc   12.49 $ 567.364  Millions$ 45.441  Millions
Pulmatrix Inc   12.43 $ 4.088  Millions$ 0.329  Millions

Date modified: 2026-09-18T13:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.